These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12040372)

  • 1. Methylation matters: a new spin on maspin.
    Costello JF; Vertino PM
    Nat Genet; 2002 Jun; 31(2):123-4. PubMed ID: 12040372
    [No Abstract]   [Full Text] [Related]  

  • 2. Role for DNA methylation in the control of cell type specific maspin expression.
    Futscher BW; Oshiro MM; Wozniak RJ; Holtan N; Hanigan CL; Duan H; Domann FE
    Nat Genet; 2002 Jun; 31(2):175-9. PubMed ID: 12021783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.
    Boltze C; Schneider-Stock R; Quednow C; Hinze R; Mawrin C; Hribaschek A; Roessner A; Hoang-Vu C
    Int J Mol Med; 2003 Oct; 12(4):479-84. PubMed ID: 12964023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic regulation of maspin expression in the human placenta.
    Dokras A; Coffin J; Field L; Frakes A; Lee H; Madan A; Nelson T; Ryu GY; Yoon JG; Madan A
    Mol Hum Reprod; 2006 Oct; 12(10):611-7. PubMed ID: 16936308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer.
    Bettstetter M; Woenckhaus M; Wild PJ; Rümmele P; Blaszyk H; Hartmann A; Hofstädter F; Dietmaier W
    J Pathol; 2005 Apr; 205(5):606-14. PubMed ID: 15714592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylation.
    Yatabe Y; Mitsudomi T; Takahashi T
    Oncogene; 2004 May; 23(23):4041-9. PubMed ID: 15048080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines.
    Guilleret I; Benhattar J
    Biochem Biophys Res Commun; 2004 Dec; 325(3):1037-43. PubMed ID: 15541393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
    Liu Z; Shi HY; Nawaz Z; Zhang M
    Cancer Lett; 2004 Jun; 209(1):55-65. PubMed ID: 15145521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of maspin expression in human ovarian carcinoma cells.
    Rose SL; Fitzgerald MP; White NO; Hitchler MJ; Futscher BW; De Geest K; Domann FE
    Gynecol Oncol; 2006 Aug; 102(2):319-24. PubMed ID: 16457875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
    Esteller M
    Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.
    Agathanggelou A; Dallol A; Zöchbauer-Müller S; Morrissey C; Honorio S; Hesson L; Martinsson T; Fong KM; Kuo MJ; Yuen PW; Maher ER; Minna JD; Latif F
    Oncogene; 2003 Mar; 22(10):1580-8. PubMed ID: 12629521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant maspin expression in human endometrial cancer.
    Murai S; Maesawa C; Masuda T; Sugiyama T
    Cancer Sci; 2006 Sep; 97(9):883-8. PubMed ID: 16822296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: maspin as a molecular target for cancer therapy.
    Domann FE; Futscher BW
    J Urol; 2003 Mar; 169(3):1162-4. PubMed ID: 12576873
    [No Abstract]   [Full Text] [Related]  

  • 14. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
    Soejima H; Nakagawachi T; Zhao W; Higashimoto K; Urano T; Matsukura S; Kitajima Y; Takeuchi M; Nakayama M; Oshimura M; Miyazaki K; Joh K; Mukai T
    Oncogene; 2004 May; 23(25):4380-8. PubMed ID: 15007390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-specific imprinting of the ZAC/PLAGL1 tumour suppressor gene results from variable utilization of monoallelic and biallelic promoters.
    Valleley EM; Cordery SF; Bonthron DT
    Hum Mol Genet; 2007 Apr; 16(8):972-81. PubMed ID: 17341487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression.
    Kim S; Han J; Kim J; Park C
    Cancer Res; 2004 Oct; 64(19):6900-5. PubMed ID: 15466179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer.
    Lopez-Serra L; Ballestar E; Fraga MF; Alaminos M; Setien F; Esteller M
    Cancer Res; 2006 Sep; 66(17):8342-6. PubMed ID: 16951140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation and gene silencing in cancer: which is the guilty party?
    Clark SJ; Melki J
    Oncogene; 2002 Aug; 21(35):5380-7. PubMed ID: 12154400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
    Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The roles of DNA methylation in human neoplasms].
    Yuan YF; Li JQ; Yang ZL; Wang JP
    Ai Zheng; 2002 Nov; 21(11):1267-77. PubMed ID: 12526230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.